Literature DB >> 9573122

Differential early interactions between Salmonella enterica serovar Typhi and two other pathogenic Salmonella serovars with intestinal epithelial cells.

D L Weinstein1, B L O'Neill, D M Hone, E S Metcalf.   

Abstract

Salmonella enterica serovar Typhi (hereafter referred to as S. typhi) is a host-restricted pathogen that adheres to and invades the distal ileum and subsequently disseminates to cause typhoid fever in humans. However, S. typhi appears to be avirulent in small animals. In contrast, other pathogenic salmonellae, such as S. enterica serovars Typhimurium and Dublin (S. typhimurium and S. dublin, respectively), typically cause localized gastroenteritis in humans but have been used as models for typhoid fever because these organisms cause a disease in susceptible rodents that resembles human typhoid. In vivo, S. typhi has been demonstrated to attach to and invade murine M cells but is rapidly cleared from the Peyer's patches without destruction of the M cells. In contrast, invasion of M cells by S. typhimurium is accompanied by destruction of these M cells and subsequently sloughing of the epithelium. These data have furthered our view that the early steps in the pathogenesis of typhoidal and nontyphoidal Salmonella serovars are distinct. To extend this concept, we have utilized an in vitro model to evaluate three parameters of initial host-pathogen interactions: adherence of three Salmonella serovars to human and murine small intestinal epithelial cell (IEC) lines, the capacity of these salmonellae to invade IECs, and the ability of the bacteria to induce interleukin-6 (IL-6) in these cell lines as a measure of host cell activation and the host acute-phase response. The results demonstrate that S. typhi adheres to and invades human small IECs better than either S. typhimurium or S. dublin. Interestingly, invA and invE null mutants of S. typhi are able neither to adhere to nor to invade IECs, unlike S. typhimurium invA and invE mutants, which adhere to but cannot invade IECs. S. typhi also induces significantly greater quantities of IL-6 in human small IEC lines than either of the other two Salmonella serovars. These findings suggest that differential host cytokine responses to bacterial pathogens may play an important role in the pathological sequelae that follow infection. Importantly, S. typhimurium did not induce IL-6 in murine IECs. Since S. typhimurium infection in mice is often used as a model of typhoid fever, these findings suggest that, at least in this case, the mouse model does not reflect the human disease. Taken together, our studies indicate that (i) marked differences occur in the initial steps of S. typhi, S. typhimurium, and S. dublin pathogenesis, and (ii) conclusions about S. typhi pathogenesis that have been drawn from the mouse model of typhoid fever should be interpreted conservatively.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573122      PMCID: PMC108196          DOI: 10.1128/IAI.66.5.2310-2318.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  The establishment of strains of human cells in tissue culture.

Authors:  G HENLE; F DEINHARDT
Journal:  J Immunol       Date:  1957-07       Impact factor: 5.422

2.  Summary of an international workshop on typhoid fever.

Authors:  R Edelman; M M Levine
Journal:  Rev Infect Dis       Date:  1986 May-Jun

Review 3.  Typhoid fever: pathogenesis and immunologic control.

Authors:  R B Hornick; S E Greisman; T E Woodward; H L DuPont; A T Dawkins; M J Snyder
Journal:  N Engl J Med       Date:  1970-09-24       Impact factor: 91.245

4.  Genetics of resistance to infection with Salmonella typhimurium in mice.

Authors:  J Plant; A A Glynn
Journal:  J Infect Dis       Date:  1976-01       Impact factor: 5.226

5.  The ability of Salmonella to enter mammalian cells is affected by bacterial growth state.

Authors:  C A Lee; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  Cytopathogenic effect of Salmonella typhi GIFU 10007 on M cells of murine ileal Peyer's patches in ligated ileal loops: an ultrastructural study.

Authors:  S Kohbata; H Yokoyama; E Yabuuchi
Journal:  Microbiol Immunol       Date:  1986       Impact factor: 1.955

7.  Innate resistance of mice to Salmonella typhi infection.

Authors:  A D O'Brien
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

8.  Growth of salmonellae in orally infected germfree mice.

Authors:  F M Collins; P B Carter
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

9.  Interleukin-6 induced at mucosal surfaces by gram-negative bacterial infection.

Authors:  P de Man; C van Kooten; L Aarden; I Engberg; H Linder; C Svanborg Edén
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

10.  Growth of typhoid and paratyphoid bacilli in intravenously infected mice.

Authors:  P B Carter; F M Collins
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

View more
  26 in total

1.  New Insights into the Roles of Long Polar Fimbriae and Stg Fimbriae in Salmonella Interactions with Enterocytes and M Cells.

Authors:  Amanda M Gonzales; Shyra Wilde; Kenneth L Roland
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

2.  Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi.

Authors:  Javier Santander; Soo-Young Wanda; Cheryl A Nickerson; Roy Curtiss
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

3.  Host restriction of Salmonella enterica serotype Typhi is not caused by functional alteration of SipA, SopB, or SopD.

Authors:  Manuela Raffatellu; Yao-Hui Sun; R Paul Wilson; Quynh T Tran; Daniela Chessa; Helene L Andrews-Polymenis; Sara D Lawhon; Josely F Figueiredo; Renée M Tsolis; L Garry Adams; Andreas J Bäumler
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  An inducible and secreted eukaryote-like serine/threonine kinase of Salmonella enterica serovar Typhi promotes intracellular survival and pathogenesis.

Authors:  Nagaraja Theeya; Atri Ta; Sayan Das; Rahul S Mandal; Oishee Chakrabarti; Saikat Chakrabarti; Amar N Ghosh; Santasabuj Das
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

5.  Three-dimensional tissue assemblies: novel models for the study of Salmonella enterica serovar Typhimurium pathogenesis.

Authors:  C A Nickerson; T J Goodwin; J Terlonge; C M Ott; K L Buchanan; W C Uicker; K Emami; C L LeBlanc; R Ramamurthy; M S Clarke; C R Vanderburg; T Hammond; D L Pierson
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

6.  M cell-targeted DNA vaccination.

Authors:  Y Wu; X Wang; K L Csencsits; A Haddad; N Walters; D W Pascual
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

7.  Absence of all components of the flagellar export and synthesis machinery differentially alters virulence of Salmonella enterica serovar Typhimurium in models of typhoid fever, survival in macrophages, tissue culture invasiveness, and calf enterocolitis.

Authors:  C K Schmitt; J S Ikeda; S C Darnell; P R Watson; J Bispham; T S Wallis; D L Weinstein; E S Metcalf; A D O'Brien
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

8.  Environmental regulation of Salmonella typhi invasion-defective mutants.

Authors:  G J Leclerc; C Tartera; E S Metcalf
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

9.  Evaluation of a novel Vi conjugate vaccine in a murine model of salmonellosis.

Authors:  Christine Hale; Frances Bowe; Derek Pickard; Simon Clare; Jean-Francois Haeuw; Ultan Powers; Nathalie Menager; Pietro Mastroeni; Gordon Dougan
Journal:  Vaccine       Date:  2006-03-20       Impact factor: 3.641

10.  Bacterial and host factors involved in the major histocompatibility complex class Ib-restricted presentation of Salmonella Hsp 60: novel pathway.

Authors:  Wei-Feng Lo; Cory D Dunn; Helena Ong; Eleanor S Metcalf; Mark J Soloski
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.